Effect of Prophylactic Treatment with Intravesical Epirubicin on Recurrence of Superficial Bladder Cancer—The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG):: A Randomized Trial of Intravesical Epirubicin at Dose of 20mg/40ml, 30mg/40ml, 40mg/40ml
- 31 May 2004
- journal article
- clinical trial
- Published by Elsevier BV in European Urology
- Vol. 45 (5), 600-605
- https://doi.org/10.1016/j.eururo.2003.12.010
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Factors Explaining Recurrence in Patients Undergoing Chemoimmunotherapy Regimens for Frequently Recurring Superficial Bladder CarcinomaEuropean Urology, 2002
- Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resectionCancer, 1999
- A Prospective European Organization for Research and Treatment of Cancer Genitourinary Group Randomized Trial Comparing Transurethral Resection Followed by a Single Intravesical Instillation of Epirubicin or Water in Single Stage Ta, T1 Papillary Carcinoma of the BladderJournal of Urology, 1993
- Tests for trend in life table analysisBiometrika, 1975